Subsidies for Implants at Public Healthcare Institutions

What is the Implant Subsidy List (ISL)?

The ISL aims to extend subsidies to and encourage the use of clinically effective and cost-effective implants to improve patient outcomes and healthcare resource utilisation.

The ISL comprises implants¹ assessed to be safe, clinically and cost-effective. Patients will be eligible for means-tested subsidies when these implants are used in Public Healthcare Institutions (PHIs) in accordance with the clinical criteria for subsidy eligibility as stipulated in the ISL.

Download the Implant Subsidy List (accurate as of 28 November 2025).

¹ Implants are a subset of medical technologies that are placed inside or on the surface of the human body. The ISL has referenced the definition of implants from the Health Products Act, Health Products (Medical Devices) Regulation 2010.

Am I allowed to use implants not listed in the ISL?

Implants that are not listed on the Implant Subsidy List can be broadly classified into two groups:

(1) Implant categories that have yet to transit to the ISL

Patients who use these implants will continue to be eligible for subsidies under the Capped Implant Subsidy Framework:

• Singapore Citizens: Up to 50%, capped at $1,000

• Permanent Residents: Up to 25%, capped at $500

Please refer to the lists below for implant categories that have transited to the ISL and those that are currently under assessment.

Implant categories that have transited to the Implant Subsidy List as of 28 November 2025

• Cardiac Implantable Electronic Devices

• Active Middle Ear Implants

• Bone Conduction Hearing Implants

• Cochlear Implants

• Transcatheter Aortic Valve Implantation Devices

• Transcatheter Mitral Valve Leaflet Repair Devices

• Ossicular Middle Ear Implants

• Hip, Knee and Sports Medicine Implants

• Interventional Cardiology Implants

• Aortic Implants

• Glaucoma Treatment Implants

• Intraocular Lens

• Urogenital Implants

• Gastroenterology Implants

• Vascular Patency and Embolic Management Implants

• Neurovascular Implants

• Vascular Occlusion, Access and Closure Implants

• Spine Implants

• Mammary Implants

• Craniomaxillofacial and Oculoplastic Implants

• Dermal Substitute

• Brachytherapy

• Nerve Stimulation - Deep Brain & Vagal

• Nerve Stimulation - Spinal Cord

• Dural Patch & Aneurysm Clips

• Trauma Implants and Joint (including shoulder, elbow, wrist, finger, ankle, foot) Replacement Implants

• Hernia Repair Meshes

Implant categories currently under assessment as of 28 November 2025

• Neurosurgical Catheters and Drains

• Bone cement and bone graft

• Structural Heart

(2) Implants that have been assessed to be not clinically- and cost-effective

Patients may use implants that are not listed on the ISL, though this is generally not encouraged. The use of implants that are not clinically- and cost-effective will not be accorded subsidies and patients can expect to pay more. Patients may approach their public healthcare provider to explore subsidised options listed on the ISL.

What are the benefits?

Eligible patients will receive subsidies based on the subsidy framework of the setting where the procedure was performed:

• Acute Inpatient Subsidy

• Day Surgery and Day Operation Subsidy

• Specialist Outpatient Clinic

Who is eligible?

Any subsidised patient in a Public Healthcare Institution who meets the clinical criteria indicated for implants listed on the ISL will receive subsidies based on the prevailing subsidy framework of the setting where the implant procedure was conducted.

How do I apply?

No application is required. Subsidies are automatically accorded based on your means-test status for each episode.

You may request for more information through your public healthcare institution or healthcare service provider.

For more questions, check out our FAQs at AskMOH.